Wells Fargo raised the firm’s price target on Cigna to $334 from $300 and keeps an Equal Weight rating on the shares after the company posted solid Q3 results. Fundamentals generally appear to be on track despite strong gross profit growth at Evernorth not fully translating to earnings the way it has for Pharmacy Services peers, the firm argues.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CI:
- Cigna explores sale of Medicare Advantage business, Reuters reports
- Cigna price target raised to $327 from $300 at RBC Capital
- Cigna raises FY23 adjusted EPS view to $24.75 from $24.70, consensus $24.80
- The Cigna Group Reports Strong Third Quarter 2023 Results, Raises 2023 Adjusted EPS, Revenue, and Cash Flow Outlook
- Cigna reports Q3 adjusted EPS $6.77, consensus $6.67
